January 13, 2012 -- NovaBay® Pharma of California signed a partnership agreement with Pioneer Pharma, a Shanghai company that distributes high-end medical products in China. The agreement gives Pioneer responsibility for China commercialization of NovaBay’s anti-infective wound-cleaning product, NeutroPhase. NovaBay received an upfront payment of over $300,000, and it could earn pre-launch milestones of an additional $1 million. More details....
Stock Symbol: (AMEX: NBY)
